Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104651292A reveals high-purity S-CHBE synthesis via recombinant E. coli. Achieves 100% conversion and 99.4% ee for scalable pharmaceutical intermediates.
Patent CN103122355A details a thermostable ketoreductase enabling high-purity chiral alcohol manufacturing with significant cost reduction and supply chain reliability.
Patent CN103290078B reveals purified enzyme catalysis for 5-aminovaleric acid production offering simplified separation and high yield for scalable polymer intermediate manufacturing supply chains.
Patent CN117165543A reveals a high-yield biocatalytic route for furfuryl alcohol. Discover cost-effective manufacturing and supply chain advantages for fine chemical intermediates.
Patent CN106496146A reveals a sulfonic acid ionic liquid catalyzed method for high-yield quinazolinone synthesis, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN102911229B reveals a greener synthesis route for Cytidine using polymer-supported catalysts, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Novel acenaphthopyrazino quinoxaline synthesis patent CN114507237B enables high quantum efficiency OLED materials with scalable production capabilities for global supply chains.
Novel intermediates and methods for CPT-11 and mappicine synthesis offering improved yield and chiral control for pharmaceutical manufacturing supply chains.
Patent CN108587991A reveals novel aminotransferase and isomerase pairs for L-allo-Ile production. Discover green enzymatic methods for high-purity pharmaceutical intermediates and cost reduction.
Novel TEMPO-catalyzed oxidative cyclization for 1,2,3,4-tetrahydrocinnoline scaffolds. Mild conditions, high yields, scalable process for anticancer drug development.
Patent CN115948360A details an imine reductase mutant achieving >99.5% conversion and 99.6% ee for nicotine analog intermediates, offering significant cost and supply chain advantages.
Patent CN104630125B reveals engineered E. coli for high-purity statin intermediate synthesis with mild conditions and reduced processing complexity.
Novel patent CN115417776B offers high-yield 2-amino-1-propanol synthesis. Reduces waste and cost for pharmaceutical intermediates supply chain reliability.
Patent CN105001085B reveals layered catalyst method. High purity, recyclable catalyst, cost reduction in agrochemical intermediate manufacturing.
Patent CN101547893B reveals a novel salt recovery method for biphenylalanine, enabling cost reduction in pharmaceutical intermediate manufacturing through direct extraction and recycling.
Advanced solid acid catalysis for bisphenol fluorene manufacturing ensures high purity and supply chain stability for global polymer and electronic chemical buyers.
Patent CN113667704B reveals a green two-step enzymatic route for high-purity (R)-DMPM. This method offers significant cost reduction and supply chain reliability for agrochemical manufacturers.
Novel one-pot synthesis for diene rhodium(I) nitrate. Reduces cost, enhances purity above 99 percent. Ideal for pharma and fine chemical manufacturing supply chains.
Patent CN107488639A reveals a novel toluene monooxygenase for high-purity chiral sulfoxide production. Discover green biocatalytic advantages for pharmaceutical supply chains.
Patent CN102942553A reveals a high-yield route for 6-carboxyfluorescein using SnCl4, offering superior isomer ratios and cost-effective manufacturing for fluorescence labeling intermediates.